BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12555357)

  • 21. [Heparin-induced thrombocytopenia].
    Christoffersen C; Lethagen S; Gøtze JP
    Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Heparin-induced thrombocytopenia].
    Cruz-González I; Sánchez-Ledesma M; Sánchez PL; Jang IK
    Rev Esp Cardiol; 2007 Oct; 60(10):1071-82. PubMed ID: 17953929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-induced thrombocytopenia.
    Prescrire Int; 2013 May; 22(138):124-5. PubMed ID: 23819174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multidisciplinary consultation for the prescription of danaparoid in suspected heparin-induced thrombocytopenia].
    Verdy E; Debrix I; Benomar A; Becker A; Flahault A
    Presse Med; 2007 May; 36(5 Pt 1):786-93. PubMed ID: 17303370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-induced thrombocytopenia and cardiovascular diseases.
    Das P; Ziada K; Steinhubl SR; Moliterno DJ; Hamdalla H; Jozic J; Mukherjee D
    Am Heart J; 2006 Jul; 152(1):19-26. PubMed ID: 16824828
    [No Abstract]   [Full Text] [Related]  

  • 26. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
    Hassell K
    Chest; 2005 Feb; 127(2 Suppl):1S-8S. PubMed ID: 15706025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Warkentin TE; Greinacher A
    Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia: laboratory diagnosis and management.
    Elalamy I; Lecrubier C; Horellou MH; Conard J; Samama MM
    Ann Med; 2000 Dec; 32 Suppl 1():60-7. PubMed ID: 11209984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.
    Napolitano LM; Warkentin TE; Almahameed A; Nasraway SA
    Crit Care Med; 2006 Dec; 34(12):2898-911. PubMed ID: 17075368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and development of heparin-induced thrombocytopenia. Biological and clinical aspects].
    Elalamy I; Page Y; Viallon A; Tardy B; Conard J; Helft G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):961-74. PubMed ID: 10907445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-induced thrombocytopenia and its treatment.
    Warkentin TE
    J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S29-35. PubMed ID: 10859582
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 33. Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.
    Hale LP; Smith K; Braden GA; Owen J
    Cathet Cardiovasc Diagn; 1998 Nov; 45(3):318-22. PubMed ID: 9829897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopenia.
    Schenk JF; Pindur G; Stephan B; Mörsdorf S; Mertzlufft F; Kroll H; Wenzel E; Seyfert UT
    Clin Appl Thromb Hemost; 2003 Jan; 9(1):25-32. PubMed ID: 12643320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases.
    Tardy-Poncet B; Wolf M; Lasne D; Bauters A; Ffrench P; Elalamy I; Tardy B
    Intensive Care Med; 2009 Aug; 35(8):1449-53. PubMed ID: 19350215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Am J Cardiovasc Drugs; 2001; 1(6):429-43. PubMed ID: 14728002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of orgaran in hemodialysis during heparin-induced thrombopenia].
    Lamriben L; Tiberghien F; Delacour JL; Floriot C; Wagschal G; Daoudal P; Ory JP
    Presse Med; 1996 Sep; 25(28):1303. PubMed ID: 8949796
    [No Abstract]   [Full Text] [Related]  

  • 38. Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II.
    Zöhrer' B; Zenz W; Rettenbacher A; Covi P; Kurnik K; Kroll H; Grubbauer HM; Muntean W
    Acta Paediatr; 2001 Jul; 90(7):765-71. PubMed ID: 11519979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current recommendations for diagnosis and therapy of heparin-induced thrombocytopenia].
    Hinz P; Lubenow N; Eckernkamp A; Geinacher A
    Unfallchirurg; 2002 Sep; 105(9):845-50. PubMed ID: 12232745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hitting back HIT.
    Gude D
    Ann Card Anaesth; 2012; 15(2):168-9. PubMed ID: 22508216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.